Get the Stockscreener App
8.55
0.12%
0.01
After Hours:
8.55
Y Mabs Therapeutics Inc Stock (YMAB) Forecast
The Y Mabs Therapeutics Inc (YMAB) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $32.40, representing a +278.98% increase from the current price of $8.55. The highest analyst price target is $36.70, and the lowest is $28.11.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month YMAB Price Target
Average 34.55
(+304.07% Upside)
Is Y Mabs Therapeutics Inc (YMAB) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 81.53 | Sell |
| STOCH(9,6) | 67.30 | Neutral |
| STOCHRSI(14) | 64.29 | Neutral |
| MACD(12,26) | 0.8447 | Sell |
| ADX(14) | 52.64 | Buy |
| William %R | -16.67 | Sell |
| CCI(14) | 1.3703 | Neutral |
Buy: 1
Sell: 3
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
8.526
Buy
|
8.3986
Buy
|
| MA20 |
7.903
Buy
|
7.8015
Buy
|
| MA50 |
5.895
Buy
|
6.527
Buy
|
| MA100 |
5.1685
Buy
|
6.0455
Buy
|
| MA200 |
6.3408
Buy
|
7.0356
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, YMAB could be considered a Strong Buy, with 17 technical analysis indicators signaling 11 Buy signals, 3 signaling Sell signals and 3 Neutral signals. This might be a good time to open fresh positions on YMAB, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 81.53 indicates that YMAB is overbought. This suggests that YMAB price has experienced a significant increase over a specified lookback period, potentially leading to a correction.
- STOCH (Stochastic Oscillator): The STOCH value of 67.3 indicates that YMAB is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 64.29 indicates that YMAB is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 52.64 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 1.3703 indicates that YMAB is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term YMAB price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Y Mabs Therapeutics Inc financial reports and earnings history, Y Mabs Therapeutics Inc (YMAB) stock could reach $11.08 by 2030, $8.0004 by 2040 and $16.06 by 2050. See the projected annual prices until 2050 of the Y Mabs Therapeutics Inc stock below:
- Y Mabs Therapeutics Inc (YMAB) is expected to reach an average price of $3.6518 in 2035, with a high prediction of $3.5953 and a low estimate of $3.8844. This indicates an $-57.29% rise from the last recorded price of $8.55.
- Y Mabs Therapeutics Inc (YMAB) stock is projected to chart a bullish course in 2040, with an average price target of $8.2015, representing an $-4.08% surge from its current level. The forecast ranges from a conservative $8.5778 to a sky-high $8.0004.
- Our analysts predict Y Mabs Therapeutics Inc (YMAB) to jump -31.60% by 2045, soaring from $5.9538 to an average price of $5.8486, potentially reaching $4.7786. While $5.9538 is the low estimate, the potential upside is significant.
- Y Mabs Therapeutics Inc (YMAB) stock is expected to climb by 2050, reaching an average of $13.34, a $56.07% jump from its current level. However, a wide range of estimates exists, with high and low targets of $16.06 and $16.94, respectively, highlighting the market's uncertainty.
Y Mabs Therapeutics Inc Stock (YMAB) Year by Year Forecast
Y Mabs Therapeutics Inc Stock (YMAB) Price Forecast for 2025
Y Mabs Therapeutics Inc Stock (YMAB) is expected to reach an average price of $26.64 in 2025, with a high prediction of $44.85 and a low estimate of $8.436. This indicates an +211.63% rise from the last recorded price of $8.55.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| September, 2025 | $32.43 | $28.11 | $36.70 | +279.31% |
| October, 2025 | $32.89 | $30.44 | $38.08 | +284.66% |
| November, 2025 | $32.84 | $30.55 | $37.58 | +284.09% |
| December, 2025 | $37.22 | $31.71 | $38.33 | +335.29% |
Y Mabs Therapeutics Inc Stock (YMAB) Price Forecast for 2026
The predicted value for Y Mabs Therapeutics Inc (YMAB) in 2026 is set at an average of $34.55. Estimates vary from a peak of $49.70 to a trough of $19.39, indicating an +304.07% surge from the present price of $8.55.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $42.69 | $34.39 | $49.70 | +399.28% |
| February, 2026 | $48.28 | $42.37 | $49.52 | +464.68% |
| March, 2026 | $42.09 | $41.87 | $49.39 | +392.30% |
| April, 2026 | $36.32 | $34.55 | $45.27 | +324.79% |
| May, 2026 | $29.59 | $24.36 | $37.32 | +246.09% |
| June, 2026 | $20.99 | $20.75 | $31.17 | +145.53% |
| July, 2026 | $28.83 | $19.39 | $29.89 | +237.19% |
| August, 2026 | $30.95 | $27.46 | $33.05 | +262.01% |
| September, 2026 | $27.63 | $25.69 | $32.41 | +223.14% |
| October, 2026 | $23.93 | $23.53 | $34.53 | +179.89% |
| November, 2026 | $25.51 | $21.85 | $26.03 | +198.39% |
| December, 2026 | $23.30 | $22.50 | $29.35 | +172.51% |
Y Mabs Therapeutics Inc Stock (YMAB) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Y Mabs Therapeutics Inc (YMAB) is $12.83, with a high forecast of $24.29 and a low forecast of $1.3786. This indicates an +50.11% increase from the last price of $8.55.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $21.33 | $20.41 | $24.29 | +149.48% |
| February, 2027 | $12.95 | $12.71 | $23.29 | +51.49% |
| March, 2027 | $10.98 | $9.7798 | $13.30 | +28.42% |
| April, 2027 | $6.9715 | $6.3315 | $12.89 | -18.46% |
| May, 2027 | $2.5732 | $2.2932 | $6.9066 | -69.90% |
| June, 2027 | $2.9803 | $1.3786 | $4.4603 | -65.14% |
| July, 2027 | $6.8021 | $2.9158 | $8.2966 | -20.44% |
| August, 2027 | $5.8838 | $5.8338 | $9.2129 | -31.18% |
| September, 2027 | $6.6309 | $2.2801 | $6.6399 | -22.45% |
| October, 2027 | $6.4926 | $5.3926 | $9.0822 | -24.06% |
| November, 2027 | $14.33 | $6.9381 | $14.81 | +67.65% |
| December, 2027 | $13.34 | $10.16 | $15.52 | +56.04% |
Y Mabs Therapeutics Inc Stock (YMAB) Price Forecast for 2028
In 2028, Y Mabs Therapeutics Inc (YMAB) is projected to reach an average price of $7.0682, with a high projection of $13.96 and a low estimate of $0.1804. This indicates an -17.33% fall from the last price of $8.55.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $10.97 | $9.6178 | $13.96 | +28.34% |
| February, 2028 | $9.5049 | $8.2049 | $11.99 | +11.17% |
| March, 2028 | $1.2779 | $1.3479 | $11.00 | -85.05% |
| April, 2028 | $0.6762 | $1.0017 | $1.1525 | -92.09% |
| May, 2028 | $0.2491 | $0.3991 | $0.5055 | -97.09% |
| June, 2028 | $0.3474 | $0.3728 | $0.3318 | -95.94% |
| July, 2028 | $0.6356 | $0.3511 | $0.1965 | -92.57% |
| August, 2028 | $1.5485 | $0.8902 | $0.8294 | -81.89% |
| September, 2028 | $0.9832 | $0.1804 | $1.5576 | -88.50% |
| October, 2028 | $2.1849 | $0.7595 | $2.4286 | -74.45% |
| November, 2028 | $3.4721 | $1.8104 | $6.2358 | -59.39% |
| December, 2028 | $2.1138 | $1.8338 | $4.2029 | -75.28% |
Y Mabs Therapeutics Inc Stock (YMAB) Price Forecast for 2029
The 2029 price forecast for Y Mabs Therapeutics Inc Stock (YMAB) is $8.2396 on average, with a high prediction of $16.45 and a low estimate of $0.0328. This represents an -3.63% decrease from the previous price of $8.55.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $1.4409 | $1.2009 | $2.8101 | -83.15% |
| February, 2029 | $0.9326 | $0.0328 | $1.8826 | -89.09% |
| March, 2029 | $0.3844 | $0.1289 | $1.0261 | -95.50% |
| April, 2029 | $0.7161 | $0.3398 | $1.2651 | -91.62% |
| May, 2029 | $0.4932 | $0.1526 | $1.2232 | -94.23% |
| June, 2029 | $1.6249 | $0.1387 | $2.2495 | -80.99% |
| July, 2029 | $2.3067 | $1.5204 | $3.1067 | -73.02% |
| August, 2029 | $8.3038 | $1.9721 | $8.8988 | -2.88% |
| September, 2029 | $12.05 | $7.2248 | $12.81 | +40.88% |
| October, 2029 | $11.79 | $9.2227 | $16.45 | +37.93% |
| November, 2029 | $10.71 | $8.9189 | $13.06 | +25.31% |
| December, 2029 | $10.50 | $9.8698 | $12.60 | +22.81% |
Y Mabs Therapeutics Inc Stock (YMAB) Price Forecast for 2030
Y Mabs Therapeutics Inc Stock (YMAB) is expected to reach an average price of $13.65 in 2030, with a high forecast of $24.58 and a low forecast of $2.712. This signifies an +59.61% surge from the last price of $8.55.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $10.36 | $7.0934 | $11.08 | +21.22% |
| February, 2030 | $11.03 | $8.3751 | $11.20 | +28.98% |
| March, 2030 | $11.29 | $10.26 | $11.89 | +32.06% |
| April, 2030 | $14.55 | $9.062 | $16.97 | +70.17% |
| May, 2030 | $14.49 | $13.47 | $20.36 | +69.46% |
| June, 2030 | $19.07 | $11.69 | $19.48 | +123.07% |
| July, 2030 | $17.05 | $13.49 | $21.21 | +99.38% |
| August, 2030 | $20.31 | $17.11 | $22.87 | +137.54% |
| September, 2030 | $20.21 | $18.27 | $22.21 | +136.41% |
| October, 2030 | $21.49 | $17.86 | $24.58 | +151.32% |
| November, 2030 | $6.8112 | $6.1813 | $23.42 | -20.34% |
| December, 2030 | $12.01 | $2.712 | $14.39 | +40.52% |
0.98%
8.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):